Terms: = Lung cancer AND ERG, P11308, 2078 AND Treatment
36 results:
1. Interaction, immune infiltration characteristics and prognostic modeling of efferocytosis-related subtypes in glioblastoma.
Zhao S; Wang Q; Liu Y; Zhang P; Ji W; Xie J; Cheng C
BMC Med Genomics; 2023 Oct; 16(1):248. PubMed ID: 37853449
[TBL] [Abstract] [Full Text] [Related]
2. SCN4B inhibits the progression of lung adenocarcinoma and is associated with better prognosis.
Ma M; Guo B; Lu H; Hong L
Clin Respir J; 2023 Dec; 17(12):1233-1245. PubMed ID: 37826914
[TBL] [Abstract] [Full Text] [Related]
3. Club-like cells in proliferative inflammatory atrophy of the prostate.
Huang FW; Song H; Weinstein HN; Xie J; Cooperberg MR; Hicks J; Mummert L; De Marzo AM; Sfanos KS
J Pathol; 2023 Sep; 261(1):85-95. PubMed ID: 37550827
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis.
Ding Q; Wang K; Li Y; Peng P; Zhang D; Chang D; Wang W; Ren L; Tang F; Li Z
Am J Clin Oncol; 2023 Jul; 46(7):284-292. PubMed ID: 37145881
[TBL] [Abstract] [Full Text] [Related]
5. Pralsetinib for RET Fusion-Positive Advanced Non-small-Cell lung cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Al Khayat MNMT; Armstrong N; Howick J; O'Meara S; Posadzki P; Ryder S; Ahmadu C; Konings SRA; Postma MJ; Duffy S; Wolff RF; van Asselt ADI
Pharmacoeconomics; 2023 Apr; 41(4):353-361. PubMed ID: 36757608
[TBL] [Abstract] [Full Text] [Related]
6. Targeting cyclin-dependent kinase 7-association between CDK7 and pMED1 expression in prostate cancer tissue.
Paulsen FO; Kang D; Becker F; Roth D; Joerg V; Dreyer E; Roesch MC; Seidel C; Merseburger AS; Kirfel J; Sailer V; Offermann A; Perner S
Carcinogenesis; 2022 Sep; 43(8):779-786. PubMed ID: 35512686
[TBL] [Abstract] [Full Text] [Related]
7. A YAP1::TFE3 cutaneous low-grade fibromyxoid neoplasm: A novel entity!
Patton A; Bridge JA; Liebner D; Chung C; Iwenofu OH
Genes Chromosomes Cancer; 2022 Apr; 61(4):194-199. PubMed ID: 34874592
[TBL] [Abstract] [Full Text] [Related]
8. Anti-metastatic effects of ergosterol peroxide from the entomopathogenic fungus Ophiocordyceps gracilioides on 4T1 breast cancer cells.
Shin MK; Sasaki F; Ki DW; Win NN; Morita H; Hayakawa Y
J Nat Med; 2021 Sep; 75(4):824-832. PubMed ID: 33905080
[TBL] [Abstract] [Full Text] [Related]
9. Autophagy and PTEN in DNA damage-induced senescence.
Sharma A; Almasan A
Adv Cancer Res; 2021; 150():249-284. PubMed ID: 33858598
[TBL] [Abstract] [Full Text] [Related]
10. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
11. Early initiated postoperative rehabilitation enhances quality of life in patients with operable lung cancer: Secondary outcomes from a randomized trial.
Sommer MS; Vibe-Petersen J; Stærkind MB; Langer SW; Larsen KR; Trier K; Christensen M; Clementsen PF; Missel M; Christensen KB; Lillelund C; Langberg H; Pedersen JH; Quist M
Lung Cancer; 2020 Aug; 146():285-289. PubMed ID: 32593918
[TBL] [Abstract] [Full Text] [Related]
12. Durvalumab for the treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell lung cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Witlox WJA; van Asselt ADI; Wolff R; Armstrong N; Worthy G; Chalker A; Buksnys T; Stirk L; Kleijnen J; Joore MA; Grimm SE
Pharmacoeconomics; 2020 Apr; 38(4):317-324. PubMed ID: 31814080
[TBL] [Abstract] [Full Text] [Related]
13. treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract] [Full Text] [Related]
14. Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell lung cancer: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.
Claxton L; O'Connor J; Woolacott N; Wright K; Hodgson R
Pharmacoeconomics; 2019 May; 37(5):645-654. PubMed ID: 30298279
[TBL] [Abstract] [Full Text] [Related]
15. Solitary pulmonary capillary hemangioma: Clinicopathologic and radiologic characteristics of nine surgically resected cases.
Zhao J; Shao J; Zhu L; Yu K; Zhao R; Ding W; Zhang J; Han Y
Pathol Res Pract; 2018 Nov; 214(11):1885-1891. PubMed ID: 30268596
[TBL] [Abstract] [Full Text] [Related]
16. The clinical features of epithelioid hemangioendothelioma in a Han Chinese population: A retrospective analysis.
Guo Q; Xue J; Xu L; Shi Z; Zhou B
Medicine (Baltimore); 2017 Jun; 96(26):e7345. PubMed ID: 28658152
[TBL] [Abstract] [Full Text] [Related]
17. Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell lung cancer and erg-Rearrangements in Prostate cancer.
Catelain C; Pailler E; Oulhen M; Faugeroux V; Pommier AL; Farace F
Adv Exp Med Biol; 2017; 994():169-179. PubMed ID: 28560674
[TBL] [Abstract] [Full Text] [Related]
18. Amplification of EGFR Wild-Type Alleles in Non-Small Cell lung cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors.
Nukaga S; Yasuda H; Tsuchihara K; Hamamoto J; Masuzawa K; Kawada I; Naoki K; Matsumoto S; Mimaki S; Ikemura S; Goto K; Betsuyaku T; Soejima K
Cancer Res; 2017 Apr; 77(8):2078-2089. PubMed ID: 28202511
[TBL] [Abstract] [Full Text] [Related]
19. [Pulmonary epithelioid hemangioendothelioma: a clinicopathologic analysis of six cases].
Ding ZY; Zhang RS; Yu B; Wang XT; Lu ZF; Shi QL; Zhou XJ; Shen Q
Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):622-5. PubMed ID: 27646891
[TBL] [Abstract] [Full Text] [Related]
20. Method for semi-automated microscopy of filtration-enriched circulating tumor cells.
Pailler E; Oulhen M; Billiot F; Galland A; Auger N; Faugeroux V; Laplace-Builhé C; Besse B; Loriot Y; Ngo-Camus M; Hemanda M; Lindsay CR; Soria JC; Vielh P; Farace F
BMC Cancer; 2016 Jul; 16():477. PubMed ID: 27417942
[TBL] [Abstract] [Full Text] [Related]
[Next]
